1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Avantor, Inc.
  6. Summary
    AVTR   US05352A1007

AVANTOR, INC.

(AVTR)
  Report
Delayed Nyse  -  04:00 2022-07-05 pm EDT
31.50 USD   -0.35%
07/05Evercore ISI Adjusts Avantor's Price Target to $38 From $40, Maintains Outperform Rating
MT
06/30Avantor® to Host Second Quarter 2022 Earnings Call on Friday, July 29, 2022
PR
06/29Avantor Named Best Company for Upstream Processing and Single-Use Solutions at BMK 2022
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/28/2022 06/29/2022 06/30/2022 07/01/2022 07/05/2022 Date
31.62(c) 31.5(c) 31.1(c) 31.61(c) 31.5(c) Last
4 023 633 2 798 125 4 220 166 4 274 658 2 628 515 Volume
-1.16% -0.38% -1.27% +1.64% -0.35% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 7 967 M - -
Net income 2022 739 M - -
Net Debt 2022 5 958 M - -
P/E ratio 2022 28,4x
Yield 2022 0,07%
Sales 2023 8 455 M - -
Net income 2023 929 M - -
Net Debt 2023 5 028 M - -
P/E ratio 2023 23,2x
Yield 2023 0,03%
Capitalization 19 226 M 19 226 M -
EV / Sales 2022 3,16x
EV / Sales 2023 2,87x
Nbr of Employees 13 500
Free-Float 96,4%
More Financials
Company
Avantor, Inc. is a global provider of mission critical products and services to customers in the biopharma, healthcare, education and government, and applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, specialized formulated silicone... 
More about the company
Ratings of Avantor, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about AVANTOR, INC.
07/05Evercore ISI Adjusts Avantor's Price Target to $38 From $40, Maintains Outperform Ratin..
MT
06/30Avantor® to Host Second Quarter 2022 Earnings Call on Friday, July 29, 2022
PR
06/29Avantor Named Best Company for Upstream Processing and Single-Use Solutions at BMK 2022
AQ
06/24AVANTOR, INC.(NYSE : AVTR) dropped from Russell 2500 Growth Index
CI
06/24AVANTOR, INC.(NYSE : AVTR) added to Russell Small Cap Comp Value Index
CI
06/24AVANTOR, INC.(NYSE : AVTR) added to Russell 3000E Value Index
CI
06/24AVANTOR, INC.(NYSE : AVTR) added to Russell Midcap Value Index
CI
06/24AVANTOR, INC.(NYSE : AVTR) added to Russell 1000 Value Index
CI
06/24AVANTOR, INC.(NYSE : AVTR) added to Russell 3000 Value Index
CI
06/24AVANTOR, INC.(NYSE : AVTR) dropped from Russell 2500 Index
CI
06/23Avantor, GeminiBio Partner Over Provision of Custom Hydrated Services, Cell Culture Med..
MT
06/23Avantor® to Collaborate with GeminiBio to Bring Custom Hydrated Solutions and Cell Cult..
PR
06/23Avantor to Collaborate with GeminiBio to Bring Custom Hydrated Solutions and Cell Cultu..
CI
06/14Avantor Seeks M&A
CI
06/14TRANSCRIPT : Avantor, Inc. Presents at Goldman Sachs 43rd Annual Global Healthcare Confere..
CI
More news
News in other languages on AVANTOR, INC.
06/23Avantor et GeminiBio s'associent pour fournir des services hydratés sur mesure et des m..
06/23Avantor va collaborer avec GeminiBio pour offrir des solutions hydratées et des milieux..
06/14Avantor cherche une fusion-acquisition
05/13Avantor nomme Jonathan Peacock président
05/12Avantor, Inc. annonce des changements au conseil d'administration
More news
Analyst Recommendations on AVANTOR, INC.
More recommendations
Chart AVANTOR, INC.
Duration : Period :
Avantor, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AVANTOR, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 17
Last Close Price 31,50 $
Average target price 42,33 $
Spread / Average Target 34,4%
EPS Revisions
Managers and Directors
Michael Stubblefield President, Chief Executive Officer & Director
Thomas A. Szlosek Chief Financial Officer & Executive Vice President
Jonathan M. Peacock Chairman
Michael Wondrasch Chief Information Officer & Executive VP
Sheri Lewis Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
AVANTOR, INC.-25.25%19 226
ABBOTT LABORATORIES-22.34%192 989
MEDTRONIC PLC-12.53%121 417
BECTON, DICKINSON AND COMPANY0.88%71 779
BAXTER INTERNATIONAL INC.-23.82%32 976
HOYA CORPORATION-31.01%31 454